Core Financial Statements From 2010 to 2024

CLB Stock  USD 16.99  0.49  2.97%   
Core Laboratories financial statements provide useful quarterly and yearly information to potential Core Laboratories NV investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Core Laboratories financial statements helps investors assess Core Laboratories' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Core Laboratories' valuation are summarized below:
Gross Profit
96.1 M
Profit Margin
0.0719
Market Capitalization
770 M
Enterprise Value Revenue
1.967
Revenue
509.8 M
We have found one hundred twenty available fundamental signals for Core Laboratories NV, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Core Laboratories NV prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.
Check Core Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.8 M, Interest Expense of 10.1 M or Selling General Administrative of 34.3 M, as well as many exotic indicators such as Short Term Coverage Ratios of 2.31, Price Earnings Ratio of 37.49 or Price To Sales Ratio of 2.7. Core financial statements analysis is a perfect complement when working with Core Laboratories Valuation or Volatility modules.
  
This module can also supplement Core Laboratories' financial leverage analysis and stock options assessment as well as various Core Laboratories Technical models . Check out the analysis of Core Laboratories Correlation against competitors.

Core Laboratories Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets550.5 M592.6 M581.4 M
Slightly volatile
Short and Long Term Debt Total217.2 M215.4 M258.4 M
Pretty Stable
Other Current Liabilities48 M43.8 M55.5 M
Pretty Stable
Total Current Liabilities100.6 M87.5 M105 M
Very volatile
Property Plant And Equipment Net120.1 M153.5 M136.8 M
Slightly volatile
Net Debt187 M200.3 M240.4 M
Pretty Stable
Retained Earnings196.4 M98.8 M191.9 M
Slightly volatile
Accounts Payable35.9 M33.5 M38 M
Pretty Stable
Cash14.4 M15.1 M16.9 M
Slightly volatile
Non Current Assets Total325.5 M369.6 M360.1 M
Slightly volatile
Cash And Short Term Investments14.4 M15.1 M16.9 M
Slightly volatile
Net Receivables128.5 M109.4 M130.3 M
Pretty Stable
Common Stock Shares Outstanding40.8 M47.5 M44.9 M
Very volatile
Liabilities And Stockholders Equity550.5 M592.6 M581.4 M
Slightly volatile
Non Current Liabilities Total267.3 M271.1 M334 M
Pretty Stable
Inventory39.7 M71.7 M44 M
Slightly volatile
Other Current Assets26.5 M26.8 M29 M
Pretty Stable
Total Liabilities367.9 M358.5 M439 M
Pretty Stable
Property Plant And Equipment Gross118.3 M181 M138.5 M
Slightly volatile
Total Current Assets225 M223 M221.3 M
Very volatile
Intangible Assets6.4 M6.7 M9.6 M
Pretty Stable
Common Stock Total Equity1.1 M1.4 M1.2 M
Slightly volatile
Common Stock1.1 M1.4 M1.2 M
Slightly volatile
Other Liabilities66.4 M86.9 M81.3 M
Slightly volatile
Other Assets123.5 M117.7 M77.3 M
Slightly volatile
Long Term Debt229.8 M198.2 M245.3 M
Very volatile
Property Plant Equipment126.1 M181 M133.8 M
Slightly volatile
Current Deferred Revenue11.4 M6.8 M11.5 M
Pretty Stable
Good Will166.7 M114.4 M155.7 M
Slightly volatile
Warrants7.1 MM8.7 M
Slightly volatile
Non Current Liabilities Other50.3 M86.9 M48.8 M
Slightly volatile
Long Term Debt Total211.3 M155.1 M250.6 M
Slightly volatile
Capital Surpluse63.7 M117.6 M57.2 M
Slightly volatile
Deferred Long Term Asset Charges81.3 M77.4 M35.4 M
Slightly volatile
Short and Long Term Debt239.9 M204.7 M258.8 M
Slightly volatile
Long Term Investments3.9 M5.1 M3.4 M
Slightly volatile
Cash And Equivalents15.8 M17.7 M14.8 M
Pretty Stable
Net Invested Capital265.8 M155.1 M334.5 M
Slightly volatile
Net Working Capital83.1 M97.7 M101.4 M
Pretty Stable
Capital Stock1.3 M1.4 M1.2 M
Slightly volatile
Capital Lease Obligations51.1 M45 M69.4 M
Slightly volatile

Core Laboratories Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization21.8 M15.8 M21.4 M
Very volatile
Selling General Administrative34.3 M43.8 M41.8 M
Pretty Stable
Total Revenue619.3 M509.8 M675 M
Slightly volatile
Gross Profit171.1 M94 M187.9 M
Slightly volatile
Other Operating Expenses494 M456 M531.1 M
Pretty Stable
Operating Income51.1 M53.8 M137.4 M
Slightly volatile
EBIT51.1 M53.8 M137.1 M
Slightly volatile
EBITDA66.1 M69.6 M158 M
Slightly volatile
Cost Of Revenue448.2 M415.7 M487.1 M
Pretty Stable
Total Operating Expenses45.7 M40.3 M44 M
Very volatile
Selling And Marketing Expenses5.5 M6.2 M6.7 M
Slightly volatile
Interest Income9.8 M10.4 M12 M
Slightly volatile
Reconciled Depreciation17 M15.4 M22.3 M
Slightly volatile
Non Recurring97.8 M110 M119.8 M
Slightly volatile

Core Laboratories Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow13.5 M14.2 M106.6 M
Slightly volatile
Begin Period Cash Flow29.9 M15.4 M25.8 M
Slightly volatile
Depreciation21.8 M15.8 M21.4 M
Very volatile
Capital Expenditures10.1 M10.6 M19.8 M
Slightly volatile
Total Cash From Operating Activities23.5 M24.8 M126.3 M
Slightly volatile
End Period Cash Flow14.4 M15.1 M16.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.71.64634.2943
Slightly volatile
Dividend Yield0.00210.00220.0146
Very volatile
Operating Cycle127141109
Slightly volatile
Days Of Payables Outstanding32.329.416628.8952
Very volatile
Operating Cash Flow Per Share0.50.52162.8338
Slightly volatile
Price To Operating Cash Flows Ratio17.6833.85625.9354
Pretty Stable
Free Cash Flow Per Share0.280.2992.3923
Slightly volatile
Price To Free Cash Flows Ratio62.0159.06136.8853
Slightly volatile
Inventory Turnover9.225.798211.1885
Slightly volatile
Payables Turnover10.1412.40812.9078
Very volatile
Operating Profit Margin0.140.10550.1805
Slightly volatile
Long Term Debt To Capitalization0.390.41070.603
Very volatile
Cash Per Share0.460.31820.3865
Pretty Stable
Total Debt To Capitalization0.410.42540.6079
Very volatile
Interest Coverage3.84.005213.0686
Slightly volatile
Return On Capital Employed0.210.10650.2879
Slightly volatile
Ebit Per Revenue0.140.10550.1805
Slightly volatile
Quick Ratio1.871.4231.444
Slightly volatile
Net Income Per E B T0.540.99340.7902
Pretty Stable
Cash Ratio0.320.17290.1799
Very volatile
Cash Conversion Cycle95.0411280.4975
Slightly volatile
Operating Cash Flow Sales Ratio0.04620.04860.1627
Slightly volatile
Days Of Inventory Outstanding66.162.950837.3245
Slightly volatile
Days Of Sales Outstanding89.7878.29473.9708
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.480.57320.7624
Slightly volatile
Cash Flow Coverage Ratios0.140.1430.506
Slightly volatile
Current Ratio2.672.5492.1617
Pretty Stable
Fixed Asset Turnover5.733.32185.1236
Slightly volatile
Price Cash Flow Ratio17.6833.85625.9354
Pretty Stable
Enterprise Value Multiple14.2914.941222.8874
Very volatile
Debt Ratio0.290.29250.4111
Very volatile
Cash Flow To Debt Ratio0.140.1430.506
Slightly volatile
Price Sales Ratio2.71.64634.2943
Slightly volatile
Receivables Turnover3.74.66194.9876
Pretty Stable
Asset Turnover0.890.86031.1431
Slightly volatile
Gross Profit Margin0.20.18450.2503
Slightly volatile

Core Fundamental Market Drivers

Forward Price Earnings25
Cash And Short Term Investments15.1 M

Core Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Core Laboratories Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Core Laboratories income statement, its balance sheet, and the statement of cash flows. Core Laboratories investors use historical funamental indicators, such as Core Laboratories's revenue or net income, to determine how well the company is positioned to perform in the future. Although Core Laboratories investors may use each financial statement separately, they are all related. The changes in Core Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Core Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Core Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Core Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue6.8 M11.4 M
Total Revenue509.8 M619.3 M
Cost Of Revenue415.7 M448.2 M
Ebit Per Revenue 0.11  0.14 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Core Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Core Laboratories' short interest history, or implied volatility extrapolated from Core Laboratories options trading.

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Stock

  0.62NR Newpark Resources Financial Report 7th of May 2024 PairCorr

Moving against Core Stock

  0.55NOA North American Const Financial Report 24th of April 2024 PairCorr
The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.
The correlation of Core Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out the analysis of Core Laboratories Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.72)
Dividend Share
0.04
Earnings Share
0.51
Revenue Per Share
10.92
Quarterly Revenue Growth
0.005
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.